DK1492501T3 - Fremgangsmåder med anvendelse af lamellare legemer til terapeutiske formål - Google Patents

Fremgangsmåder med anvendelse af lamellare legemer til terapeutiske formål

Info

Publication number
DK1492501T3
DK1492501T3 DK03722717T DK03722717T DK1492501T3 DK 1492501 T3 DK1492501 T3 DK 1492501T3 DK 03722717 T DK03722717 T DK 03722717T DK 03722717 T DK03722717 T DK 03722717T DK 1492501 T3 DK1492501 T3 DK 1492501T3
Authority
DK
Denmark
Prior art keywords
methods
therapeutic purposes
lamellar bodies
lamellar
bodies
Prior art date
Application number
DK03722717T
Other languages
Danish (da)
English (en)
Inventor
James Dobbie
Original Assignee
Lamellar Biomedical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lamellar Biomedical Ltd filed Critical Lamellar Biomedical Ltd
Application granted granted Critical
Publication of DK1492501T3 publication Critical patent/DK1492501T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK03722717T 2002-04-03 2003-04-02 Fremgangsmåder med anvendelse af lamellare legemer til terapeutiske formål DK1492501T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207653.7A GB0207653D0 (en) 2002-04-03 2002-04-03 Methods of using lamellar bodies for therapeutic purposes
PCT/GB2003/001451 WO2003082245A1 (en) 2002-04-03 2003-04-02 Methods of using lamellar bodies for therapeutic purposes

Publications (1)

Publication Number Publication Date
DK1492501T3 true DK1492501T3 (da) 2009-04-06

Family

ID=9934144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03722717T DK1492501T3 (da) 2002-04-03 2003-04-02 Fremgangsmåder med anvendelse af lamellare legemer til terapeutiske formål

Country Status (11)

Country Link
US (1) US7906139B2 (de)
EP (2) EP1492501B1 (de)
JP (1) JP4657608B2 (de)
AT (1) ATE416756T1 (de)
AU (1) AU2003229881A1 (de)
DE (1) DE60325194D1 (de)
DK (1) DK1492501T3 (de)
ES (2) ES2409757T3 (de)
GB (1) GB0207653D0 (de)
PT (1) PT1492501E (de)
WO (1) WO2003082245A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
CA2540328C (en) * 2003-09-25 2012-11-20 Lamellar Therapeutics Limited Compositions and methods of using lamellar bodies for therapeutic purposes
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
WO2008019048A1 (en) * 2006-08-04 2008-02-14 Meditrina Pharmaceuticals Use of aromatase inhibitors for thining the endometrium or treating menorrhagia
FR2921253B1 (fr) * 2007-09-26 2012-11-16 Lvmh Rech Composition cosmetique sous la forme d'une emulsion comprenant une phase aqueuse continue et une phase grasse dispersee et son procede de preparation
DE102008005172A1 (de) * 2008-01-19 2009-07-23 Mike Ehrlich Pharmazeutische Zusammensetzung zur Verhinderung von post-operativen Adhäsionen
US20090252785A1 (en) * 2008-03-26 2009-10-08 University Of Oxford Endoplasmic reticulum targeting liposomes
US20150366952A1 (en) * 2014-06-24 2015-12-24 Saint Louis University Methods for reducing fibrosis induced by peritoneal dialysis
US20200326354A1 (en) * 2017-10-06 2020-10-15 Sime Diagnostics Ltd. Lamellar body purification for diagnosis and treatment of a disease or disorder
WO2019202326A1 (en) * 2018-04-17 2019-10-24 Lamellar Biomedical Limited Antifibrotic composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5403592A (en) 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
JPH01295933A (ja) 1989-03-25 1989-11-29 Toto Ltd 衛生洗浄装置
JPH02295933A (ja) * 1989-05-10 1990-12-06 Wakamoto Pharmaceut Co Ltd 封入純度の高いプラスミノーゲン活性化因子封入リポソームの製造法
WO1991012026A1 (en) * 1990-02-14 1991-08-22 Macnaught Pty Limited Means of reducing surgical adhesions
JPH09504517A (ja) * 1993-09-27 1997-05-06 スミスクライン・ビーチャム・コーポレイション カンプトテシン処方物
US5462752A (en) * 1994-07-28 1995-10-31 Prp, Inc. Inhibition of platelet binding
US5736157A (en) * 1995-10-11 1998-04-07 Williams; Kevin Jon Method of regulating cholesterol related genes, enzymes and other compounds, and pharmaceutical compositions
AU7685798A (en) * 1997-05-29 1998-12-30 Applied Biotechnologies Inc. Compositions and methods for preventing adhesion
SE9702698D0 (sv) * 1997-07-14 1997-07-14 Stig Bengmark Compositions for lubricating and separating tissues and biological membranes
GB9807298D0 (en) * 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
EP1183011A4 (de) * 1999-05-14 2005-01-19 Esperion Luv Dev Inc Verfahren zur behandlung von angina und/oder anginaähnlichen erkrankungen sowie die diesbezüglichen arzneimittel und kits
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
CA2319928A1 (en) * 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments

Also Published As

Publication number Publication date
US7906139B2 (en) 2011-03-15
EP1492501A1 (de) 2005-01-05
AU2003229881A1 (en) 2003-10-13
ATE416756T1 (de) 2008-12-15
PT1492501E (pt) 2009-03-26
JP2005526101A (ja) 2005-09-02
DE60325194D1 (de) 2009-01-22
EP2177212B1 (de) 2013-03-06
US20040126420A1 (en) 2004-07-01
GB0207653D0 (en) 2002-05-15
EP1492501B1 (de) 2008-12-10
ES2319276T3 (es) 2009-05-06
WO2003082245A1 (en) 2003-10-09
EP2177212A1 (de) 2010-04-21
ES2409757T3 (es) 2013-06-27
JP4657608B2 (ja) 2011-03-23

Similar Documents

Publication Publication Date Title
CY2013022I1 (el) Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK1567152T3 (da) Anvendelse af rasagilin med riluzol til behandling af amyotroph lateral sklerose
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
DK1660057T3 (da) Kombinationsterapi til behandling af neovaskulære øjenlidelser
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
IS7099A (is) Efnasambönd til að meðhöndla bólgutruflanir
NO20034056D0 (no) Proliferative sykdommer
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
EP1583997A4 (de) Photoresistentfernung
DK1663287T3 (da) Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DK2189162T3 (da) Fremgangsmåder til behandling af cellulære proliferative forstyrrelser
DK1492501T3 (da) Fremgangsmåder med anvendelse af lamellare legemer til terapeutiske formål
DK1727801T3 (da) Til behandling af smerter anvendelige piperaziner
SE0301650D0 (sv) Novel compounds
DK1558246T3 (da) Prolinderivater med affinitet for calcimkanalens alpha-2-delta subunit
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme